Fingerprint
Dive into the research topics of 'Phase II study of the safety and antitumor activity of the hypoxia-activated prodrug TH-302 in combination with doxorubicin in patients with advanced soft tissue sarcoma'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically